All Stocks
pharma

SNY — Sanofi

Conviction60
Congress 90d0
Insider 90d0
Markets0
Lobbying5
Contracts3
CountryFR

SNY

Sanofi

pharma
60thin · 1 src1 source agree
📋 Lobbying

Congressional trades

No congressional trades in the last 90 days.

Prediction markets

No prediction markets reference this stock.

Lobbying filings

Last 2 years
  • CROSSROADS STRATEGIES, LLC$50K · 2026 first_quarter
    BUDCPTHCRMMMTAXTRD
  • FORBES-TATE$50K · 2026 first_quarter
    HCRMMMTAX
  • THORN RUN PARTNERS$40K · 2026 first_quarter
    MMMTAX
  • MARSHALL & POPP, LLC$60K · 2026 first_quarter
    CPTPHATAXTRD
  • CHECKMATE GOVERNMENT RELATIONS$90K · 2026 first_quarter
    HCRMED

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇫🇷 France48/100
Posture: neutralView France

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

$86.3M · 0% defense
  • Department of Health and Human Services$53.2M · Feb 1, 2025
  • Department of Health and Human Services$18.8M · Oct 1, 2016
  • Department of Health and Human Services$14.4M · May 9, 2024
f8120c2